An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
1 Department of Anesthesiology, Acibadem Mehmet Ali Aydınlar University, School of Medicine, Altunizade Acibadem Hospital, Istanbul, Turkey.
2 Neurology, Acibadem Mehmet Ali Aydınlar University, School of Medicine, Altunizade Acibadem Hospital, Istanbul, Turkey.
3 Infectious Diseases, Acibadem Mehmet Ali Aydınlar University, School of Medicine, Altunizade Acibadem Hospital, Istanbul, Turkey.
4 Radiology, and Center for Neuroradiological Applications and Research, Acibadem Mehmet Ali Aydınlar University, School of Medicine, Altunizade Acibadem Hospital, Istanbul, Turkey.
5 Neurology, Acibadem Mehmet Ali Aydınlar University, School of Medicine, Altunizade Acibadem Hospital, Istanbul, Turkey. Electronic address: nazire.afsar@acibadem.com.
1 Department of Anesthesiology, Acibadem Mehmet Ali Aydınlar University, School of Medicine, Altunizade Acibadem Hospital, Istanbul, Turkey.
2 Neurology, Acibadem Mehmet Ali Aydınlar University, School of Medicine, Altunizade Acibadem Hospital, Istanbul, Turkey.
3 Infectious Diseases, Acibadem Mehmet Ali Aydınlar University, School of Medicine, Altunizade Acibadem Hospital, Istanbul, Turkey.
4 Radiology, and Center for Neuroradiological Applications and Research, Acibadem Mehmet Ali Aydınlar University, School of Medicine, Altunizade Acibadem Hospital, Istanbul, Turkey.
5 Neurology, Acibadem Mehmet Ali Aydınlar University, School of Medicine, Altunizade Acibadem Hospital, Istanbul, Turkey. Electronic address: nazire.afsar@acibadem.com.
Severe SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19-related autoimmune meningoencephalitis in the Intensive Care Unit (ICU).
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Fig. 1
Case 1: A through C.…
Fig. 1
Case 1: A through C. A: Axial FLAIR showing bilateral segmental frontal cortical…
Fig. 1
Case 1: A through C. A: Axial FLAIR showing bilateral segmental frontal cortical hyperintensity together with focal effacement of right frontal sulci. T1WI images showed mild pial-subarachnoid enhancement after I.V. Gad and DWI showed frontal cortical hyperintensity without matching hypointensity on ADC mapping (data not provided). All findings were considered compatible with meningoencephalitis. Following plasmapheresis, there was prominent regression of FLAIR findings at the first (B) and second (C) week’s follow-up imaging. Similarly, DWI hyperintensities disappeared and contrast enhancement regressed following treatment (data not provided). Case 2: D through F. D: Axial FLAIR showing bilateral extensive hyperintense signal changes of the frontal and parietal white matter accompanied by focal frontal cortical hyperintensity. As in Case 1, DWI images showed matching areas of diffusion restrictions (data not provided); the findings were considered compatible with meningoencephalitis. Following plasmapheresis, there was a prominent regression on FLAIR at the first (E) and second (F) week’s follow-up imaging. These also showed linear pial-subarachnoid hyperintensity within the right frontal sulci on the second week’s follow-up FLAIR compatible with subarachnoid hemorrhage (F).
Fig. 2
Ferritin levels before and after…
Fig. 2
Ferritin levels before and after plasmapheresis. (Pf: plasmapheresis).
Fig. 2
Ferritin levels before and after plasmapheresis. (Pf: plasmapheresis).
Ritchie Andrew I, Singanayagam Aran. Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? The Lancet. 2020;395(10230):1111. doi: 10.1016/S0140-6736(20)30691-7.
-
DOI
-
PMC
-
PubMed
Baig A.M., Khaleeq A., Ali U., Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem. Neurosci. 2020;11(7):995–998. doi: 10.1021/acschemneuro.0c00122. Epub 2020 Mar 13.
-
DOI
-
PubMed
Duong L., Xu P., Liu A. Meningoencephalitis without respiratory failure in a young female patient with COVID-19 Infection in Downtown Los Angeles, Early April 2020. Brain, Behavior. Immun. 2020 doi: 10.1016/j.bbi.2020.04.024.
-
DOI
-
PMC
-
PubMed
Faure E., Poissy J., Goffard A. Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside? PLoS One. 2014;9
-
PMC
-
PubMed
He L., Ding Y., Zhang Q., Che X., He Y., Shen H., Wang H. Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J. Pathol. 2006;210:288–297.
-
PMC
-
PubMed